IMMUPHARMA (IMM.L)
17 May 2017
Northland Capital Partners Morning Report
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Northland Capital Partners Morning Report
ImmuPharma plc (IMM:LON) | 2.4 0 0.0% | Mkt Cap: 9.93m
- Published:
17 May 2017 -
Author:
Vadim Alexandre -
Pages:
8
IMMUPHARMA (IMM.L)